Table 1.
Identification of top 10 differentially expressed mRNAs in each category of each NAC cohort in Baseline
| Category 1 | Category 2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||
| GSE32603 | GSE87455 | GSE32603 | GSE87455 | ||||||||
|
|
|
|
|
||||||||
| mRNA | logFC | P-Value | mRNA | logFC | P-Value | mRNA | logFC | P-Value | mRNA | logFC | P-Value |
| C4A | -1.574 | 0.002 | ANKRD30A | -2.154 | 0.001 | LITAF | 3.450 | 0.011 | MUCL1 | 3.597 | 0.022 |
| GTF2IRD1 | 1.436 | 0.005 | AGR2 | -2.043 | 0.000 | LTF | -3.277 | 0.006 | S100P | 3.176 | 0.015 |
| NTN4 | -1.404 | 0.020 | FOXA1 | -2.023 | 0.000 | UBD | -3.025 | 0.010 | MUC1 | 2.742 | 0.004 |
| C1orf35 | 1.218 | 0.003 | TFF3 | -1.992 | 0.002 | CDH2 | -2.887 | 0.006 | S100A7 | 2.720 | 0.000 |
| F2RL2 | -1.145 | 0.025 | CEACAM6 | -1.877 | 0.004 | LYZ | -2.695 | 0.007 | S100A9 | 2.708 | 0.006 |
| RARRES3 | -1.127 | 0.035 | GABRP | 1.581 | 0.003 | MAOB | -2.650 | 0.008 | S100A8 | 2.459 | 0.044 |
| CSK | 1.119 | 0.029 | PIP | -1.533 | 0.030 | S100A8 | -2.559 | 0.019 | HBA2 | -2.249 | 0.031 |
| TRIM29 | -1.082 | 0.048 | MLPH | -1.491 | 0.001 | EFHD1 | 2.511 | 0.037 | HBB | -2.243 | 0.030 |
| KRT19 | -1.076 | 0.038 | TFF1 | -1.447 | 0.022 | RMND5B | 2.354 | 0.002 | VTCN1 | 2.213 | 0.000 |
| SLC40A1 | -1.054 | 0.001 | SRARP | -1.409 | 0.004 | KRT18 | -2.342 | 0.021 | HBA1 | -2.175 | 0.033 |
Abbreviations: NAC, neoadjuvant chemotherapy; FC, fold change.